Literature DB >> 1825687

Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats.

G Shirakami1, K Nakao, Y Saito, T Magaribuchi, M Jougasaki, M Mukoyama, H Arai, K Hosoda, S Suga, Y Ogawa.   

Abstract

To investigate the effect of pulmonary alveolar hypoxia on the synthesis and release of endothelin (ET)-1, ET-1-like immunoreactivity (-LI) levels of the lung and plasma were measured in conscious unrestrained rats under hypoxic conditions. Sixty-min exposure to alveolar hypoxia (10% O2 or 5% O2) increased the ET-1-LI level in the lung. The plasma ET-1-LI level in hypoxic rats also increased significantly. The increase of plasma and lung ET-1-LI levels were parallel to the severity of hypoxia. These results demonstrates that acute pulmonary alveolar hypoxia increases lung and plasma ET-1-LI levels in conscious unrestrained rats, suggesting a possible physiological or pathophysiological significance of ET in alveolar hypoxia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825687     DOI: 10.1016/0024-3205(91)90362-f

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

Review 1.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 2.  Chronic heart failure and the immune system.

Authors:  Daniela Mari; Federica Di Berardino; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

3.  The role of endothelin-A receptors in cardiovascular responses to acute hypoxaemia in the late gestation sheep fetus.

Authors:  L R Green; H H McGarrigle; L Bennet; M A Hanson
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

4.  Mechanical and biochemical responses to endothelin-1 and endothelin-3 in bovine bronchial smooth muscle.

Authors:  J E Nally; R McCall; L C Young; M J Wakelam; N C Thomson; J C McGrath
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

Review 5.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

6.  Endothelin-1 levels in interstitial lung disease patients during sleep.

Authors:  Georgia Trakada; Eugenia Nikolaou; Athanasia Pouli; Maria Tsiamita; Kostas Spiropoulos
Journal:  Sleep Breath       Date:  2003-09       Impact factor: 2.816

7.  Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors.

Authors:  J G Filep; M G Sirois; E Földes-Filep; A Rousseau; G E Plante; A Fournier; M Yano; P Sirois
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Plasma endothelin-1 like immunoreactivity levels in neonates.

Authors:  T Kojima; Y Isozaki-Fukuda; M Takedatsu; A Ono; Y Hirata; Y Kobayashi
Journal:  Eur J Pediatr       Date:  1992-12       Impact factor: 3.183

9.  Hypoxaemia and release of endothelin-1.

Authors:  R I Cargill; D G Kiely; R A Clark; B J Lipworth
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

10.  Hypoxia-induced accumulation of erythropoietin mRNA in isolated hepatocytes is inhibited by protein kinase C.

Authors:  K U Eckardt; A Ring; M Maier; B Gess; D Fabbro; A Kurtz
Journal:  Pflugers Arch       Date:  1994-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.